# Study of JK07 in Patients With Chronic Heart Failure

Study · id `cardio:ct-nct06369298` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06369298](<https://clinicaltrials.gov/study/NCT06369298>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06369298

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems; Heart failure  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 282 participants.

## Technical summary

Registry record NCT06369298. Randomized; triple masking; primary purpose treatment. Start 2024-03-28 (actual); primary completion 2026-10-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 282 participants (planned count; ClinicalTrials.gov record NCT06369298, source copy `cardio:ctgov-nct06369298-2026-05-22`, retrieved 2026-10-26)
- Started: 2024-03-28 (actual) (ClinicalTrials.gov record NCT06369298, source copy `cardio:ctgov-nct06369298-2026-05-22`, retrieved 2026-10-26)
- Primary completion: 2026-10-31 (anticipated) (ClinicalTrials.gov record NCT06369298, source copy `cardio:ctgov-nct06369298-2026-05-22`, retrieved 2026-10-26)
- Completion: 2026-10-31 (anticipated) (ClinicalTrials.gov record NCT06369298, source copy `cardio:ctgov-nct06369298-2026-05-22`, retrieved 2026-10-26)
- Countries: United States; Canada; China; Puerto Rico (ClinicalTrials.gov record NCT06369298, source copy `cardio:ctgov-nct06369298-2026-05-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06369298-2026-05-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: Study of JK07 in Patients With Chronic Heart Failure
- Acronym: RENEU-HF
- Condition: Heart Failure With Reduced Ejection Fraction
- Condition: Heart Failure With Preserved Ejection Fraction
- Intervention (Drug): JK07
- Intervention (Drug): Placebo
- Lead sponsor: Salubris Biotherapeutics Inc
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition terms include this condition: Heart failure with mildly reduced or preserved ejection fraction (`cardio:hfpef`)
- Registry condition terms include this condition: Heart failure with reduced ejection fraction (HFrEF) (`cardio:hfref`)

## Provenance

Content hash: 459c9ea00f6a892cbac3a5b4148a8db39148c70fab137c6f918691fbd4b6c780
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
